These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11949991)

  • 1. New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins.
    Ageno W; Turpie AG
    CMAJ; 2002 Apr; 166(7):919-24. PubMed ID: 11949991
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-molecular-weight heparins in the treatment of acute coronary syndromes.
    Turpie AG; Antman EM
    Arch Intern Med; 2001 Jun; 161(12):1484-90. PubMed ID: 11427095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin and platelet glycoprotein IIb/IIIa receptor blockade in the treatment of acute coronary syndromes: complementary or competing therapies?
    White HD
    J Invasive Cardiol; 2000 Feb; 12 Suppl A():6A-13A. PubMed ID: 10731290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin in patients with non-ST-segment elevation acute coronary syndrome: role in the emergency department.
    Goodman SG
    J Emerg Med; 2000 Oct; 19(3 Suppl):3S-11S. PubMed ID: 11050378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reliable anticoagulation in acute myocardial infarction. Acute coronary syndromes: advances with low-molecular heparin therapy].
    Z Kardiol; 1998 Dec; 87(12 Suppl Akute Koro):1-4. PubMed ID: 9884738
    [No Abstract]   [Full Text] [Related]  

  • 6. Combining treatment strategies in the 21st century: low-molecular-weight heparins in acute coronary syndromes.
    Zidar JP
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():16B-21B. PubMed ID: 10731295
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-molecular weight heparins in coronary artery disease.
    Hunt D
    Curr Atheroscler Rep; 2001 Mar; 3(2):163-8. PubMed ID: 11177661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term (28 days) prognosis between genders according to the type of coronary event (Q-wave versus non-Q-wave acute myocardial infarction versus unstable angina pectoris).
    Marrugat J; García M; Elosua R; Aldasoro E; Tormo MJ; Zurriaga O; Arós F; Masiá R; Sanz G; Valle V; López De Sá E; Sala J; Segura A; Rubert C; Moreno C; Cabadés A; Molina L; López-Sendón JL; Gil M; ; ; ; ;
    Am J Cardiol; 2004 Nov; 94(9):1161-5. PubMed ID: 15518611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of low-molecular-weight heparin in acute coronary syndromes].
    Gharbi M; Barakett N; Lahidheb DH; Smiri Z; Fehri W; Azzouzi F; Rahal N; Mhenni H; Haouala H; Guediche M
    Tunis Med; 2002 Dec; 80(12):725-32. PubMed ID: 12664498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. We must use the knowledge that we have to treat patients with acute coronary syndromes.
    White HD; Willerson JT
    Circulation; 2004 Feb; 109(6):698-700. PubMed ID: 14970103
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute coronary syndromes: new developments in pharmacological treatment strategies.
    Gylys K; Gold M
    Crit Care Nurse; 2000 Apr; Suppl():3-14; quiz 15-6. PubMed ID: 11876169
    [No Abstract]   [Full Text] [Related]  

  • 12. New trials of LMW heparins - light and heavy weight as good on short but what about longer distances?
    Wallentin L
    Eur Heart J; 1999 Nov; 20(21):1522-4. PubMed ID: 10529316
    [No Abstract]   [Full Text] [Related]  

  • 13. Contemporary view of the acute coronary syndromes.
    Moustapha A; Anderson HV
    J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of acute coronary syndromes in a new French coronary intensive care unit. The first four years of activity in the GRACE registry (Global Registry of Acute Coronary Events)].
    Philippe F; Larrazet F; Dibie A; Bouabdallah K; Carbognani D; Folliguet T; Czitrom D; Lagier A; Laborde F; Cohen A; Montalescot G
    Ann Cardiol Angeiol (Paris); 2005 Mar; 54(2):68-73. PubMed ID: 15828460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparins: a valuable tool in the treatment of acute coronary syndromes.
    Wallentin L
    Eur Heart J; 1996 Oct; 17(10):1470-6. PubMed ID: 8909901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of controlled clinical trials comparing low-molecular weight heparins with unfractionated heparin in unstable angina.
    Malhotra S; Karan RS; Bhargava VK; Pandhi P; Grover A; Sharma YP; Kumar R
    Indian Heart J; 2001; 53(2):197-202. PubMed ID: 11428477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparins better than unfractionated heparin in unstable coronary artery disease? Unstable angina pectoris/non-Q wave infarction a partly outpatient clinic condition?
    Kauw FH; Cleophas TJ; Kalmansohn RB
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):392-7. PubMed ID: 9707355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics for acute coronary syndromes: are we ready for megatrials?
    Maseri A
    Eur Heart J; 1999 Jan; 20(2):89-92. PubMed ID: 10099904
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute coronary syndromes: new medications improve prognosis.
    McKee J; St Pierre M; Talley JD
    J Ark Med Soc; 1998 Nov; 95(6):249-52. PubMed ID: 9821747
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparins: their established role in acute coronary syndromes and perspectives in atrial fibrillation.
    Melandri G; Nanni S; Tricoci P; Melloni C; Semprini F; Fallani F; Bracchetti G; Branzi A
    Haematologica; 2001 Nov; 86(11 Suppl 2):54-7. PubMed ID: 11926779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.